Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy

✍ Scribed by Thomas A Buchholz; Eugene H Huang; Donald Berry; Lajos Pusztai; Eric A Strom; Marsha D McNeese; George H Perkins; Naomi R Schechter; Henry M Kuerer; Aman U Buzdar; Vicente Valero; Kelly K Hunt; Gabriel N Hortobagyi; Aysegul A Sahin

• Book ID: 108148356
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 80 KB
• Volume: 59
• Category: Article
• ISSN: 0360-3016
• DOI: 10.1016/j.ijrobp.2004.02.018